TickerFacts.

Neuraxis, Inc (NRXS): Gross Profit

Annual figures by period end, from SEC filings.

$3.01M
Year ended 2025-12-31
$4.55M
Trailing 12 months to 2026-06-30
+8.0%
3-year compound annual growth
2022-12-31: $2.39M2023-12-31: $2.16M2024-12-31: $2.32M2025-12-31: $3.01M$3.01M
2022-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$3.01M+29.4%2026-03-19, From 2025-01-01
2024-12-31$2.32M+7.8%2026-03-19, From 2024-01-01
2023-12-31$2.16M-9.7%2025-03-20, From 2023-01-01
2022-12-31$2.39Mn/a2024-04-16, From 2022-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Neuraxis, Inc (NRXS)2025-12-31$3.01M+29.4%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$1.36M-2.9%
Hongchang International Co., Ltd (HCIL)2024-12-31$181.6K+161.9%
Nuwellis, Inc. (NUWE)2025-12-31$5.12M-9.7%
Escalon Medical Corp (ESMC)2025-06-30$5.51M+7.1%
CapsoVision, Inc (CV)2025-12-31$7.17M+12.5%
Hyperfine, Inc. (HYPR)2025-12-31$6.75M+14.6%
Guided Therapeutics Inc (GTHP)2025-12-31$571.0Kn/m
QT Imaging Holdings, Inc. (QTI)2025-12-31$8.58M+225.2%

Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗